The National Institute of Mental Health offers the NCDDG Program to support collaborative research in discovering pharmacological agents for treating mental illnesses, drug addiction, and alcohol addiction. This grant aims to accelerate drug discovery, develop tools for research, validate experimental therapies, and conduct early phase human clinical testing. Encouraging partnerships between academia and industry, the grant focuses on advancing new candidate agents for mental health and addiction treatment, as well as developing ligands for characterizing and validating drug targets. Applications are welcomed to drive innovation in the discovery and preclinical development of therapies. Closing date for submissions is February 23, 2017, 12:00:00 AM EST.
Opportunity ID: 254115
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-184 |
Funding Opportunity Title: | National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 21, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Feb 23, 2017 |
Current Closing Date for Applications: | Feb 23, 2017 |
Archive Date: | Mar 26, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education State governments City or township governments For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate tools in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready agents for the treatment of mental disorders or alcohol addiction. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate agents to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-184.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00195531 | May 23, 2014 | Apr 19, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222880 | May 23, 2016 | Feb 23, 2017 | View |
Package 1
Mandatory forms
254115 RR_SF424_2_0-2.0.pdf
254115 PHS398_ResearchPlan_2_0-2.0.pdf
254115 PHS398_CoverPageSupplement_2_0-2.0.pdf
254115 RR_KeyPersonExpanded_2_0-2.0.pdf
254115 RR_OtherProjectInfo_1_3-1.3.pdf
254115 PerformanceSite_2_0-2.0.pdf
Optional forms
254115 RR_SubawardBudget30_1_3-1.3.pdf
254115 PlannedReport-1.0.pdf
254115 PHS398_CumulativeInclusionReport-1.0.pdf
254115 PHS398_ModularBudget_1_2-1.2.pdf
254115 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
254115 RR_SF424_2_0-2.0.pdf
254115 PHS398_CoverPageSupplement_3_0-3.0.pdf
254115 RR_OtherProjectInfo_1_3-1.3.pdf
254115 PerformanceSite_2_0-2.0.pdf
254115 RR_KeyPersonExpanded_2_0-2.0.pdf
254115 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
254115 RR_Budget_1_3-1.3.pdf
254115 RR_SubawardBudget30_1_3-1.3.pdf
254115 PHS398_ModularBudget_1_2-1.2.pdf
254115 PHS_Inclusion_Enrollment_Report-1.0.pdf
254115 PHS_AssignmentRequestForm-1.0.pdf